Overview

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
This protocol will compare 24 hour glucose control for subject taking saxagliptin and metformin extended release (XR) versus metformin XR alone
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Metformin
Saxagliptin